SI2787968T1 - Učinkovita dostava lipida človeškemu solznemu filmu z uporabo sol-občutljivega emulzijskega sistema - Google Patents

Učinkovita dostava lipida človeškemu solznemu filmu z uporabo sol-občutljivega emulzijskega sistema

Info

Publication number: SI2787968T1
Authority: SI; Slovenia
Prior art keywords: salt; tear film; sensitive emulsion; emulsion system; human tear
Prior art date: 2011-12-07

Application number

SI201231783T

Other languages

English (en)

Inventor

Peter A. Simmons

Joseph G. Vehige

Original Assignee

Allergan, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-12-07

Filing date

2012-12-07

Publication date

2020-08-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47459152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2787968(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-12-07 Application filed by Allergan, Inc. filed Critical Allergan, Inc.

2020-08-31 Publication of SI2787968T1 publication Critical patent/SI2787968T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dispersion Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SI201231783T 2011-12-07 2012-12-07 Učinkovita dostava lipida človeškemu solznemu filmu z uporabo sol-občutljivega emulzijskega sistema SI2787968T1 (sl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201161568089P	2011-12-07	2011-12-07
US201261625401P	2012-04-17	2012-04-17
EP12808606.3A EP2787968B1 (en)	2011-12-07	2012-12-07	Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
PCT/US2012/068603 WO2013086438A1 (en)	2011-12-07	2012-12-07	Efficient lipid delivery to human tear film using a salt-sensitive emulsion system

Publications (1)

Publication Number	Publication Date
SI2787968T1 true SI2787968T1 (sl)	2020-08-31

Family

ID=47459152

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI201231957T SI2787969T1 (sl)	2011-12-07	2012-12-07	Učinkovita dostava lipidov v solzni film človeka z uporabo na sol občutljivega emulzijskega sistema
SI201231783T SI2787968T1 (sl)	2011-12-07	2012-12-07	Učinkovita dostava lipida človeškemu solznemu filmu z uporabo sol-občutljivega emulzijskega sistema

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SI201231957T SI2787969T1 (sl)	2011-12-07	2012-12-07	Učinkovita dostava lipidov v solzni film človeka z uporabo na sol občutljivega emulzijskega sistema

Country Status (28)

Country	Link
US (2)	US20130150324A1 (sl)
EP (5)	EP2787969B1 (sl)
JP (1)	JP6142419B2 (sl)
KR (1)	KR102017922B1 (sl)
CN (2)	CN104114152A (sl)
AR (1)	AR089123A1 (sl)
AU (2)	AU2012347459A1 (sl)
BR (1)	BR112014013820A2 (sl)
CA (1)	CA2858574C (sl)
CL (1)	CL2014001518A1 (sl)
CO (1)	CO6990739A2 (sl)
DK (2)	DK2787969T3 (sl)
ES (2)	ES2797650T3 (sl)
HK (2)	HK1201458A1 (sl)
HU (2)	HUE049489T2 (sl)
IL (1)	IL233008A (sl)
IN (1)	IN2014CN04809A (sl)
MX (1)	MX355216B (sl)
MY (1)	MY173378A (sl)
PH (2)	PH12014501296B1 (sl)
PL (2)	PL2787969T3 (sl)
PT (2)	PT2787969T (sl)
RU (1)	RU2014127074A (sl)
SG (1)	SG11201403013VA (sl)
SI (2)	SI2787969T1 (sl)
TW (1)	TWI652072B (sl)
WO (2)	WO2013086438A1 (sl)
ZA (1)	ZA201404228B (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8957048B2 (en) *	2011-10-06	2015-02-17	Allergan, Inc.	Compositions for the treatment of dry eye
US9907826B2 (en)	2011-12-07	2018-03-06	Allergan, Inc.	Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
PL3266446T3 (pl)	2016-07-07	2019-05-31	Salvat Lab Sa	Kompozycja oftalmiczna zawierająca olej rycynowy i trójgliceryd o średniej długości łańcucha
CA3032695C (en)	2016-08-19	2021-11-23	Akrivista, LLC	Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
WO2019036625A1 (en)	2017-08-18	2019-02-21	Akrivista, LLC	METHODS FOR DIAGNOSING AND TREATING DRY-LIKE SYNDROME AND COMPOSITIONS FOR TREATING A HUMAN EYE
TW202014194A (zh)	2018-04-27	2020-04-16	美商歐樂根公司	抗微生物功效增強且毒性降低之亞氯酸鈉組成物

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4201706A (en)	1978-09-22	1980-05-06	Burton, Parsons & Company, Inc.	Treatment of corneal edema
EP0028110B1 (en) *	1979-10-26	1984-03-07	Smith and Nephew Associated Companies p.l.c.	Autoclavable emulsions
US5192535A (en)	1988-02-08	1993-03-09	Insite Vision Incorporated	Ophthalmic suspensions
IT1224795B (it)	1988-12-01	1990-10-24	Sigma Tau Ind Farmaceuti	Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
ES2038580T3 (es)	1989-08-03	1994-10-16	Eisai Co Ltd	Metodo de fotoestabilizacion de soluciones oftalmicas.
US5681555A (en)	1991-04-22	1997-10-28	Gleich; Gerald J.	Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
DE4229494A1 (de)	1992-09-04	1994-03-10	Basotherm Gmbh	Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
KR970705985A (ko)	1994-09-14	1997-11-03	우에하라 아끼라	각막 장해 복구용 점안제(Eye Drops for Repairing Corneal Disturbance)
US5980865A (en)	1995-08-18	1999-11-09	Baker Norton Pharmaceuticals, Inc.	Method for treating late phase allergic reactions and inflammatory diseases
FI106923B (fi)	1997-01-03	2001-05-15	Cultor Ltd Finnsugar Bioproduc	Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa
AR002194A1 (es)	1997-03-17	1998-01-07	Sanchez Reynaldo Alemany	Instrumento computarizado para el analisis del movimiento.
IT1302307B1 (it)	1998-09-01	2000-09-05	Sigma Tau Healthscience Spa	Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
EP1131105B1 (en)	1998-11-13	2004-08-11	Continental Projects Limited	Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
JP2000159659A (ja)	1998-11-30	2000-06-13	Kazuo Tsubota	眼科用人工涙液
US6228392B1 (en)	1999-04-29	2001-05-08	Gene Tools, Llc	Osmotic delivery composition, solution, and method
KR20030023700A (ko)	2000-07-14	2003-03-19	알러간, 인코포레이티드	치료활성 성분을 함유하고 용해도가 증강된 조성물
AU781975B2 (en)	2000-09-14	2005-06-23	Hayashibara Co., Ltd	Pharmaceutical composition for ophthalmic use
PT1339418E (pt)	2000-11-08	2009-10-30	Fxs Ventures Llc	Soluções oftálmicas e para lentes de contacto melhoradas contendo sacarídeos simples como intensificadores de conservação
US7045121B2 (en)	2001-12-14	2006-05-16	Allergan, Inc.	Ophthalmic compositions for lubricating eyes and methods for making and using same
WO2004028536A1 (en)	2002-09-30	2004-04-08	Babizhayev Mark A	Method for topical treatment of eye disease and composition and device for said treatment
BR0306662A (pt) *	2002-10-18	2005-02-22	Joel S Echols	Formulação lacrimal de três camadas
US20040137079A1 (en)	2003-01-08	2004-07-15	Cook James N.	Contact lens and eye drop rewetter compositions and methods
US6635654B1 (en) *	2003-01-09	2003-10-21	Allergan, Inc.	Ophthalmic compositions containing loratadine
US20040185068A1 (en) *	2003-03-18	2004-09-23	Zhi-Jian Yu	Self-emulsifying compositions, methods of use and preparation
WO2004084877A1 (ja)	2003-03-26	2004-10-07	Menicon Co., Ltd.	眼科用組成物
TWI336257B (en) *	2003-06-13	2011-01-21	Alcon Inc	Ophthalmic compositions containing a synergistic combination of three polymers
AU2004249137B2 (en) *	2003-06-13	2010-03-11	Alcon, Inc.	Ophthalmic compositions containing a synergistic combination of two polymers
US20050009836A1 (en)	2003-06-26	2005-01-13	Laskar Paul A.	Ophthalmic composition containing quinolones and method of use
US20070077278A1 (en) *	2003-11-10	2007-04-05	Yukiko Sugihara	Polysaccharide-containing composition and tear film stabilizing ophthalmic solution
US8569367B2 (en) *	2004-11-16	2013-10-29	Allergan, Inc.	Ophthalmic compositions and methods for treating eyes
US7288520B2 (en) *	2005-07-13	2007-10-30	Allergan, Inc.	Cyclosporin compositions
US7501393B2 (en) *	2005-07-27	2009-03-10	Allergan, Inc.	Pharmaceutical compositions comprising cyclosporins
US9561178B2 (en) *	2006-07-25	2017-02-07	Allergan, Inc.	Cyclosporin compositions
WO2008035246A2 (en) *	2006-07-28	2008-03-27	Novagali Pharma Sa	Compositions containing quaternary ammonium compounds
CN101896160A (zh) *	2006-10-17	2010-11-24	阿勒根公司	环胞菌素组合物
BRPI0808410A2 (pt)	2007-02-28	2015-06-23	Aciex Therapeutics Inc	Métodos e composições para normalizar secreções da glândula meibomiana
JP4929245B2 (ja)	2008-07-31	2012-05-09	株式会社ベッセル工業	工具類のグリップ
KR101778316B1 (ko) *	2009-06-05	2017-09-13	알러간, 인코포레이티드	인공 눈물 및 치료학적 용도
WO2013049621A1 (en) *	2011-09-29	2013-04-04	The Board Of Regents Of The University Of Oklahoma	Ophthalmic compositions comprising ppar-alpha agonists and methods of production and use thereof
US8957048B2 (en) *	2011-10-06	2015-02-17	Allergan, Inc.	Compositions for the treatment of dry eye

2012
- 2012-12-07 PT PT128086071T patent/PT2787969T/pt unknown
- 2012-12-07 ES ES12808606T patent/ES2797650T3/es active Active
- 2012-12-07 PL PL12808607T patent/PL2787969T3/pl unknown
- 2012-12-07 HU HUE12808606A patent/HUE049489T2/hu unknown
- 2012-12-07 EP EP12808607.1A patent/EP2787969B1/en active Active
- 2012-12-07 CN CN201280067685.0A patent/CN104114152A/zh active Pending
- 2012-12-07 AR ARP120104614A patent/AR089123A1/es not_active Application Discontinuation
- 2012-12-07 PL PL12808606T patent/PL2787968T3/pl unknown
- 2012-12-07 ES ES12808607T patent/ES2896336T3/es active Active
- 2012-12-07 BR BR112014013820A patent/BR112014013820A2/pt not_active Application Discontinuation
- 2012-12-07 CN CN201810890387.0A patent/CN108969482A/zh active Pending
- 2012-12-07 JP JP2014546154A patent/JP6142419B2/ja active Active
- 2012-12-07 AU AU2012347459A patent/AU2012347459A1/en not_active Abandoned
- 2012-12-07 DK DK12808607.1T patent/DK2787969T3/da active
- 2012-12-07 WO PCT/US2012/068603 patent/WO2013086438A1/en active Application Filing
- 2012-12-07 CA CA2858574A patent/CA2858574C/en active Active
- 2012-12-07 EP EP21198843.1A patent/EP3981387A1/en active Pending
- 2012-12-07 KR KR1020147018598A patent/KR102017922B1/ko active Active
- 2012-12-07 SI SI201231957T patent/SI2787969T1/sl unknown
- 2012-12-07 EP EP12808606.3A patent/EP2787968B1/en active Active
- 2012-12-07 SI SI201231783T patent/SI2787968T1/sl unknown
- 2012-12-07 DK DK12808606.3T patent/DK2787968T3/da active
- 2012-12-07 HU HUE12808607A patent/HUE057140T2/hu unknown
- 2012-12-07 TW TW101146304A patent/TWI652072B/zh active
- 2012-12-07 MY MYPI2014001672A patent/MY173378A/en unknown
- 2012-12-07 MX MX2014006804A patent/MX355216B/es active IP Right Grant
- 2012-12-07 PT PT128086063T patent/PT2787968T/pt unknown
- 2012-12-07 WO PCT/US2012/068615 patent/WO2013086449A1/en active Application Filing
- 2012-12-07 EP EP20153344.5A patent/EP3666257A1/en not_active Withdrawn
- 2012-12-07 EP EP24167560.2A patent/EP4403220A3/en active Pending
- 2012-12-07 SG SG11201403013VA patent/SG11201403013VA/en unknown
- 2012-12-07 US US13/708,783 patent/US20130150324A1/en not_active Abandoned
- 2012-12-07 PH PH1/2014/501296A patent/PH12014501296B1/en unknown
- 2012-12-07 IN IN4809CHN2014 patent/IN2014CN04809A/en unknown
- 2012-12-07 PH PH1/2021/553172A patent/PH12021553172A1/en unknown
- 2012-12-07 US US13/708,771 patent/US9314528B2/en active Active
- 2012-12-07 RU RU2014127074A patent/RU2014127074A/ru unknown
2014
- 2014-06-08 IL IL233008A patent/IL233008A/en active IP Right Grant
- 2014-06-09 ZA ZA2014/04228A patent/ZA201404228B/en unknown
- 2014-06-09 CL CL2014001518A patent/CL2014001518A1/es unknown
- 2014-06-26 CO CO14138315A patent/CO6990739A2/es unknown
2015
- 2015-02-27 HK HK15102023.0A patent/HK1201458A1/xx unknown
- 2015-04-14 HK HK15103604.5A patent/HK1203057A1/xx unknown
2017
- 2017-11-27 AU AU2017265181A patent/AU2017265181B2/en active Active

Also Published As

Publication number	Publication date
EP2787968B1 (en)	2020-03-04
EP2787969A1 (en)	2014-10-15
MX2014006804A (es)	2014-09-22
SI2787969T1 (sl)	2021-12-31
DK2787968T3 (da)	2020-06-02
EP3666257A1 (en)	2020-06-17
DK2787969T3 (da)	2021-11-01
WO2013086449A1 (en)	2013-06-13
PL2787968T3 (pl)	2020-08-24
SG11201403013VA (en)	2014-07-30
HUE049489T2 (hu)	2020-09-28
BR112014013820A8 (pt)	2017-06-13
ES2797650T3 (es)	2020-12-03
CA2858574C (en)	2017-05-30
EP2787968A1 (en)	2014-10-15
AU2017265181B2 (en)	2019-06-20
TWI652072B (zh)	2019-03-01
PT2787968T (pt)	2020-06-16
RU2014127074A (ru)	2016-02-10
JP6142419B2 (ja)	2017-06-07
EP3981387A1 (en)	2022-04-13
KR20140107383A (ko)	2014-09-04
PH12014501296A1 (en)	2014-10-08
MY173378A (en)	2020-01-21
RU2018119362A (ru)	2018-11-08
ZA201404228B (en)	2015-12-23
AR089123A1 (es)	2014-07-30
CN108969482A (zh)	2018-12-11
PL2787969T3 (pl)	2021-12-20
HUE057140T2 (hu)	2022-04-28
IL233008A0 (en)	2014-07-31
IN2014CN04809A (sl)	2015-09-18
AU2017265181A1 (en)	2017-12-14
KR102017922B1 (ko)	2019-09-03
HK1201458A1 (en)	2015-09-04
CL2014001518A1 (es)	2014-10-24
TW201325633A (zh)	2013-07-01
CO6990739A2 (es)	2014-07-10
PT2787969T (pt)	2021-11-09
US20130197083A1 (en)	2013-08-01
ES2896336T3 (es)	2022-02-24
EP2787969B1 (en)	2021-09-29
BR112014013820A2 (pt)	2017-06-13
US20130150324A1 (en)	2013-06-13
MX355216B (es)	2018-04-10
CA2858574A1 (en)	2013-06-13
JP2015504860A (ja)	2015-02-16
EP4403220A2 (en)	2024-07-24
US9314528B2 (en)	2016-04-19
RU2018119362A3 (sl)	2021-09-07
CN104114152A (zh)	2014-10-22
WO2013086438A1 (en)	2013-06-13
IL233008A (en)	2017-07-31
PH12021553172A1 (en)	2024-05-27
PH12014501296B1 (en)	2023-04-05
EP4403220A3 (en)	2024-10-23
HK1203057A1 (en)	2015-10-16
AU2012347459A1 (en)	2014-07-03

Publication	Publication Date	Title
HK1203057A1 (en)	2015-10-16	Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2776114B8 (en)	2019-04-17	System for deploying a device to a distal location across a diseased vessel
EP2770493A4 (en)	2015-07-08	ADVERTISING DEVICE WITH A 3D FILM
EP2683431A4 (en)	2015-03-11	DRUG DELIVERY SYSTEM
PT2768942T (pt)	2020-01-21	Entrega intracelular
EP2729685A4 (en)	2016-09-07	SYSTEM FOR MULTI-FUEL FREEZING
EP2760316A4 (en)	2015-04-29	MODULAR DISPLAY SYSTEM
PL2560616T3 (pl)	2017-12-29	Emulsja naśladująca łzy
EP3804784C0 (en)	2024-06-26	SYSTEM AND METHOD ASSOCIATED WITH A PERISTALTIC PUMP MECHANISM
HK1199533A1 (en)	2015-07-03	Virtual advertising platform
ZA201309156B (en)	2015-02-25	Drug delivery system
HK1206292A1 (en)	2016-01-08	Medicament administration
GB201322968D0 (en)	2014-02-12	Advertising system
IL228511A0 (en)	2013-12-31	A thin and flexible sheet
GB201116598D0 (en)	2011-11-09	Interactive system
FI10064U1 (fi)	2013-04-23	Järjestelmä käyttäjien esittelemiseksi toisilleen
GB201118441D0 (en)	2011-12-07	Improvements relating to interactive retail systems
GB2489685B (en)	2017-01-25	A Display System
AU2011900296A0 (en)	2011-02-17	Improvements in tear film stability
UA22858S (uk)	2012-03-12	Упакування для лікарського засобу «віферон»
AU2011901952A0 (en)	2011-06-02	Breathing assist device
AU2011902997A0 (en)	2011-08-11	Propulsion system for propelling a person in water